Table 4: Descriptive Statistics for Pain Catastrophizing subscales at Baseline, Week 1, Week 2, and Week 3.

Assessment
Variable Group n BaselineM (SD) Week 1M (SD) Week 2M (SD) Week 3M (SD)
Rumination Experimental 9 8.22 (4.24) 5.67 (3.87) 5.78 (3.73) 3.89 (3.92)
Placebo 9 5.33 (4.18) 5.22 (4.15) 4.78 (4.87) 5.11 (4.86)
Control 10 8.90 (4.07) 7.30 (4.76) 4.50 (4.30) 6.20 (4.54)
Magnification Experimental 9 5.33 (2.78) 3.67 (2.60) 3.78 (2.28) 2.67 (2.06)
Placebo 9 3.44 (3.78) 3.67 (3.81) 3.56 (4.00) 3.33 (4.00)
Control 10 5.30 (2.91) 4.80 (3.85) 4.60 (3.06) 5.30 (3.86)
Helplessness Experimental 9 8.22 (3.80) 4.44 (2.51) 5.00 (4.18) 3.56 (4.85)
Placebo 9 6.44 (6.02) 4.56 (5.94) 4.56 (5.55) 4.11 (5.30)
Control 10 8.00 (4.47) 6.70 (5.50) 5.00 (3.97) 5.70 (6.08)

Note: Total pain catastrophizing scores range from a low of 0 to a high of 52; rumination subscale a low of 0 to a high of 16; magnification subscale a low of 0 to a high of 12; helplessness subscale a low of 0 to a high of 24.